Avoro Capital Advisors’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $262M | Buy |
|
|||||
|
2023
Q3 | $154M | Hold |
|
|||||
|
2023
Q2 | $113M | Hold |
|
|||||
|
2023
Q1 | $89.8M | Hold |
|
|||||
|
2022
Q4 | $64.6M | Hold |
|
|||||
|
2022
Q3 | $36M | Hold |
|
|||||
|
2022
Q2 | $30.4M | Hold |
|
|||||
|
2022
Q1 | $32M | Hold |
|
|||||
|
2021
Q4 | $34.8M | Hold |
|
|||||
|
2021
Q3 | $37.6M | Hold |
|
|||||
|
2021
Q2 | $44.9M | Hold |
|
|||||
|
2021
Q1 | $46.8M | Hold |
|
|||||
|
2020
Q4 | $59.1M | Hold |
|
|||||
|
2020
Q3 | $74.6M | Buy |
|
|||||
|
2020
Q2 | $18.3M | Sell |
|
|||||
|
2020
Q1 | $8.14M | Hold |
|
|||||
|
2019
Q4 | $10.8M | Buy |
|
|||||
|
2019
Q3 | $13.8M | Hold |
|
|||||
|
2019
Q2 | $19.3M | Buy |
|
|||||
|
2019
Q1 | $9.63M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $17.2M | Buy |
|